EP1404268A4 - TREATMENT OF BLEED EPIDERMOLYSIS BY THYMOSIN BETA 4 - Google Patents
TREATMENT OF BLEED EPIDERMOLYSIS BY THYMOSIN BETA 4Info
- Publication number
- EP1404268A4 EP1404268A4 EP02736866A EP02736866A EP1404268A4 EP 1404268 A4 EP1404268 A4 EP 1404268A4 EP 02736866 A EP02736866 A EP 02736866A EP 02736866 A EP02736866 A EP 02736866A EP 1404268 A4 EP1404268 A4 EP 1404268A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- epidermlyosis
- bullosa
- treating
- thymosin beta
- thymosin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- UGPMCIBIHRSCBV-XNBOLLIBSA-N Thymosin beta 4 Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(C)=O UGPMCIBIHRSCBV-XNBOLLIBSA-N 0.000 title 1
- 102100035000 Thymosin beta-4 Human genes 0.000 title 1
- 108010079996 thymosin beta(4) Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29132601P | 2001-05-17 | 2001-05-17 | |
| US291326P | 2001-05-17 | ||
| PCT/US2002/015394 WO2002091969A1 (en) | 2001-05-17 | 2002-05-16 | Treating epidermlyosis bullosa with thymosin beta 4 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1404268A1 EP1404268A1 (en) | 2004-04-07 |
| EP1404268A4 true EP1404268A4 (en) | 2006-03-01 |
Family
ID=23119854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02736866A Withdrawn EP1404268A4 (en) | 2001-05-17 | 2002-05-16 | TREATMENT OF BLEED EPIDERMOLYSIS BY THYMOSIN BETA 4 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1404268A4 (enExample) |
| JP (1) | JP2004525988A (enExample) |
| CN (1) | CN1241636C (enExample) |
| AU (1) | AU2002309842B2 (enExample) |
| CA (1) | CA2446072A1 (enExample) |
| MX (1) | MXPA03010446A (enExample) |
| WO (1) | WO2002091969A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007521336A (ja) * | 2003-12-22 | 2007-08-02 | リジェナークス・バイオファーマシューティカルズ・インコーポレイテッド | 反応性化学物質、生物学的物質、もしくは毒素に対する、生物学的もしくは免疫学的応答を、処理もしくは防止する方法 |
| EP2260106A4 (en) * | 2008-03-17 | 2011-04-20 | Regenerx Biopharmaceuticals | IMPROVED BETATHYMOSINFRAGMENTS |
| US8632827B2 (en) * | 2011-12-13 | 2014-01-21 | Avon Products, Inc | Modulation of thymosin beta-4 in skin |
| WO2014093053A1 (en) * | 2012-12-11 | 2014-06-19 | Avon Products, Inc. | Modulation of thymosin beta-4 in skin |
| CN104324279A (zh) * | 2014-11-19 | 2015-02-04 | 吕玲 | 一种治疗皮肤发育不良的中药药剂及制备方法 |
| WO2017214910A1 (zh) * | 2016-06-15 | 2017-12-21 | 石庆学 | 特异促进Tβ4基因高表达的慢病毒表达载体及其应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006190A1 (en) * | 1998-07-30 | 2000-02-10 | The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health | THYMOSIN β4 PROMOTES WOUND REPAIR |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087341A (en) * | 1998-02-12 | 2000-07-11 | The Board Of Trustees Of The Leland Standford Junior University | Introduction of nucleic acid into skin cells by topical application |
-
2002
- 2002-05-16 CN CNB028100956A patent/CN1241636C/zh not_active Expired - Fee Related
- 2002-05-16 WO PCT/US2002/015394 patent/WO2002091969A1/en not_active Ceased
- 2002-05-16 JP JP2002588889A patent/JP2004525988A/ja active Pending
- 2002-05-16 EP EP02736866A patent/EP1404268A4/en not_active Withdrawn
- 2002-05-16 AU AU2002309842A patent/AU2002309842B2/en not_active Ceased
- 2002-05-16 CA CA002446072A patent/CA2446072A1/en not_active Abandoned
- 2002-05-16 MX MXPA03010446A patent/MXPA03010446A/es not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006190A1 (en) * | 1998-07-30 | 2000-02-10 | The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health | THYMOSIN β4 PROMOTES WOUND REPAIR |
Non-Patent Citations (3)
| Title |
|---|
| MALINDA K M ET AL: "THYMOSIN BETA4 ACCELERATES WOUND HEALING", JOURNAL OF INVESTIGATIVE DERMATOLOGY, NEW YORK, NY, US, vol. 113, no. 3, September 1999 (1999-09-01), pages 364 - 368, XP009053562, ISSN: 0022-202X * |
| See also references of WO02091969A1 * |
| SIMENEL C ET AL: "Structural requirements for thymosin beta4 in its contact with actin: An NMR-analysis of thymosin beta4 mutants in solution and correlation with their biological activity", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 267, no. 12, June 2000 (2000-06-01), pages 3530 - 3538, XP002289476, ISSN: 0014-2956 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1241636C (zh) | 2006-02-15 |
| CA2446072A1 (en) | 2002-11-21 |
| CN1511017A (zh) | 2004-07-07 |
| JP2004525988A (ja) | 2004-08-26 |
| MXPA03010446A (es) | 2004-12-06 |
| WO2002091969A1 (en) | 2002-11-21 |
| EP1404268A1 (en) | 2004-04-07 |
| AU2002309842B2 (en) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9800942D0 (en) | Well treatment | |
| HUP0102808A3 (en) | Ectoparasiticide agents | |
| EP1404268A4 (en) | TREATMENT OF BLEED EPIDERMOLYSIS BY THYMOSIN BETA 4 | |
| GB2335942B (en) | Trowel | |
| GB9800536D0 (en) | Sequences | |
| GB0114066D0 (en) | Baths | |
| GB9904771D0 (en) | Trowel | |
| HK1064580A (en) | Treating epidermlyosis bullosa with thymosin beta 4 | |
| GB9814164D0 (en) | Ballscrew | |
| GB9813295D0 (en) | Bath | |
| GB9808247D0 (en) | Bath | |
| GB9818524D0 (en) | Inorgasmia treatment | |
| GB9916299D0 (en) | Dogex 1 | |
| GB0028459D0 (en) | Glor 2 | |
| GB9828550D0 (en) | Treatment | |
| IL160451A0 (en) | 17 alpha-hydroxy-14beta-steroids with hormonal effect | |
| GB9814483D0 (en) | Challenge | |
| GB9812914D0 (en) | Treatment | |
| GB2337411B (en) | Interconnect controller | |
| GB9803693D0 (en) | Hormone treatment | |
| CA83264S (en) | Shellfish-hanger pins | |
| GB9905449D0 (en) | Baths | |
| GB9806328D0 (en) | Time manipulation technique | |
| GB9901134D0 (en) | Gothic | |
| GB9809758D0 (en) | Strand treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20031204 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1064580 Country of ref document: HK |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20060113 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 17/02 20060101ALI20060109BHEP Ipc: A61K 38/22 20060101AFI20060109BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20080228 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1064580 Country of ref document: HK |